Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on March 4, 2025, the Compensation ...

Initially, Puma intends to focus the development of alisertib on the treatment of small cell lung cancer and breast cancer.

Mariadelis Labrador Siles was last seen Monday while wearing a light blue jacket and black Puma shoes with pink soles.

Puma undertakes no obligation to revise or update ... looking at the efficacy of alisertib monotherapy patients with small cell lung cancer. As a reminder, the ALISCA-Breast1 trial investigates ...

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology ... monotherapy for the treatment of patients with extensive stage small cell lung cancer (2025). Revenue Total revenue consists of product ...

Puma reckons that alisertib has potential in ... Aurora kinase A is an enzyme that is involved in cell division and proliferation, and is often overexpressed in cancers. There is evidence that ...

Puma Biotechnology PBYI reported fourth-quarter 2024 adjusted earnings of 43 cents per share, which beat the Zacks Consensus ...

The lost wonderkid who was once Jude Bellingham's roomate and found salvation in street football, now a Maradona is giving him hope.

"The marketers also put too much emphasis on range, so they had to commit to using nickel-rich cell chemistries that increase ...

She met Zach as he collected a Fraser Bear, the charity's mascot, after having a stem cell transplant as part ... who have flown Sea King, Wessex and Puma and Chinook helicopters have been ...

She met Zach as he collected a Fraser Bear, the charity's mascot, after having a stem cell transplant as part ... who have flown Sea King, Wessex and Puma and Chinook helicopters have been ...